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Abstract
Background: Whether pheromone signaling exists in humans is still a matter of intense discussion. In the present study we
tested if smelling of Androstenol, a steroid produced by the human body and reported to affect human behavior, may elicit
cerebral activation. A further issue was to evaluate whether the pattern of activation resembles the pattern of common
odors.
Methodology: PET measurements of regional cerebral blood flow (rCBF) were conducted in 16 healthy heterosexual women
during passive smelling of Androstenol, four ordinary odors (OO), and odorless air (the base line condition).
Principal findings: Smelling Androstenol caused activation of a portion of the hypothalamus, which according to animal
data mediates the pheromone triggered mating behavior. Smelling of OO, on the other hand, engaged only the classical
olfactory regions (the piriform cortex, lateral amygdala, anterior insular and anterior cingulate cortex).
Conclusions: The observed pattern of activation is very similar to the pattern previously detected with 4,16-androstadien-3-
one in heterosexual females. It suggests that several compounds released by human body may activate cerebral networks
involved in human reproduction.
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Introduction
According to the original definition by Karlson and Lucher
pheromones are chemical compounds secreted externally by some
animals (especially insects) that influences the physiology or
behavior of other animals of the same species [1]. Whilst
pheromone effects in animals are well recognized, it is controver-
sial whether they exist also in humans. Several psychophysical
studies indicate that a progesterone derivative, 4,16-androstadien-
3-one (AND) is capable of affecting mood, arousal, heart rate, as
well as cortisol levels [2,3,4,5,6,7]. Furthermore, recent brain
imaging studies show that smelling of AND, as well as of an
estrogen like compound, estra-1,3,5(10),16-tetraen-3-ol (EST),
trigger cerebral activations suggestive of pheromone signaling
[8,9,10,11]. Sobel and Gabrieli [8] observed that smelling EST
activates the thalamus, hypothalamus, and the prefrontal cortex in
men even when this steroid was presented in non-consciously
detectable concentrations. In a series of imaging studies employing
EST and AND, we found activations in the anterior hypothala-
mus, which were differentiated with respect to sex and sexual
orientation of the smeller in relation to the respective compound
[9,10,11]. Heterosexual women and homosexual men displayed
activations of the hypothalamus when smelling AND, whereas
smelling of EST recruited classical olfactory regions (the amygdala,
piriform, anterior cingulate and insular cortex). The pattern of
activation was reciprocal in heterosexual men and homosexual
women [9,10,11]. Considering that the anterior hypothalamus is
the major mediator of pheromone signals, these data strongly
argue that such signals may exist also in humans. In order for this
concept to be valid, however, several bodily released compounds
should have pheromone properties. Gas chromatographic analyses
of human body odors suggest that in addition to complex mixtures
of aliphatic carboxylic acids, volatile steroids are prime candidates
to serve pheromone function (Gowern, Ruparella 1993). Andros-
tenol (5a-androst-16-en-3a-ol) is a steroid, which like AND belongs
to the group of odorous 16-androstenes. Androstenol was first
isolated from boar testes, and several animal experiments suggest
that androstenol is capable of reducing anxiety, as well as
hippocampal epileptogenic activity [12]. It was subsequently
detected in humans, (primarily in males), in sweat, urine, plasma
and saliva [13]. Androstenol is also shown to affect hormonal,
behavioral and social responses in humans [14,15]. Of particular
note is its influence on the pulsatile secretion of luteinizing
hormone in human females, an effect assumed to be mediated by
the hypothalamic nuclei [16]. Considering that this compound
also is highly volatile (vapor pressure at 37uC is 254 microtorr), it
could be expected to act as a pheromone, provided that its signals
can be transduced to the brain. To test this possibility, we carried
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which we measured changes in cerebral blood flow during passive
smelling of Androstenol compared to smelling unscented air. Two
issues were addressed in particular:
1. Does smelling of Androstenol activate the human brain?
2. Does the site of activation correspond to activations previously
detected with ordinary odors?
Methods
Fifteen right-handed, healthy, unmedicated, heterosexual
women (age 22–38 years) were investigated during the second
to third week of the menstrual cycle. None of the subjects had
allergy, upper respiratory problems, or heredity for anosmia.
Neither did they have history of or heredity for neuropsychiatric
disorders. Their olfactory thresholds, measured prior to the PET




The study was approved by the Ethics and Radiosafety
Committees at the Karolinska Institute.
PET Experiments
Regional cerebral blood flow (rCBF) was measured during
baseline and activation using
15O-H2O-PET. During base line
(denoted AIR in the manuscript) subjects were laying in the
scanner with closed eyes, plugged ears, passively breathing of the
unscented environmental air. There were two activation
conditions: 1) birhinal smelling of Androstenol, 2) birhinal
smelling of four different odors, which were presented on line
during the same scan and denoted as OO throughout the
manuscript. The rationale for presenting four odors during the
same scan was to avoid that results would rely on one odor, but
also avoid an excessive radioactivity exposition which would be a
consequence of separate scans for the separate odors. The odors
were butanol, cedar oil, lavendel oil and eugenol. Butanol was
diluted in distilled water (10% concentration), the other odors
were not diluted. Psychophysical characteristics of the four odors
have been described in our earlier studies, which showed
reproducible activations of the amygdala, piriform cortex, and
portions of the anterior insular and cingulate cortices, in
accordance with other studies of odor activation [17,18,19,20].
These odors were used to investigate whether Androstenol
engages similar cerebral regions as the more ordinary odors.
Because, theoretically, dissolving of Androstenol could change its
possible pheromone properties we chose to present it in
crystalline and odorous form (200 mg, Steraloids, Newport, RI).
The purity was 98%, as tested repetitively at our doping
laboratory (Department of Pharmacology, Karolinska University
Hospital).
PET experiments were carried out as described previously [9].
The room temperature and air pressure were standardized (23uC,
997 hPa) [9]. Subjects were informed that they would smell either
odor or unscented air while an open and empty, or odor
containing jar was presented 10 mm under the nose, four times
during 15 seconds with 5 seconds breathing of environmental air
in-between [9,10,11]. Subjects were instructed to relax, with eyes
closed and ears plugged, and just breathe normally without sniffing
or hyperventilating (which they trained twice before the PET
sessions). There were six PET scans per person, lasting 60 seconds
(three conditions, two scans/condition, balanced and randomly
interleaved). Respiratory movements were recorded continuously
2 min before, and during each scan, by using a strain gauge
around the lower thorax connected to a graph (Comair, Stock-
holm, Sweden) as described previously [9]. When all the PET
scans were completed subjects were presented with Androstenol
and OO again and asked to rate each item for odor intensity,
irritability, pleasantness, and familiarity, using a Visual Analogue
Scale (VAS), [9,11,18]. Differences in ratings between groups were
tested with paired T-tests, one for each modality. The mean
respiratory amplitude and the frequency was first calculated
during each prescan and scan period. The baseline and scan-
associated amplitude and frequency were stable within the same
subject throughout the study but tended to vary from subject to
subject. Rather than carrying out comparisons on the basis of
absolute values during various conditions, we, therefore, analyzed
the relative change in respiratory amplitude and frequency during
each presentation by calculating the mean percentage difference
between the scan- and immediate prescan values. Mean relative
change in respiratory amplitude and frequency was compared
between AIR, Androstenol and OO by means of repeated
measures ANOVA. The significance level was 0.05 in all
comparisons.
Activations and deactivations were calculated with SPM2
software package (Wellcome Department of Cognitive Neurol-
ogy, London, http://www.fil.ion.ucl.ac.uk/spm). Activations
were defined contrasting Androstenol-AIR and OO-AIR,
Table 1. Activations and deactivations with Androstenol and OO.
Region Z level Size, cm
3 Co- ordinates Z level Size, cm
3 Co- ordinates
Activation Androstenol - AIR OO - AIR
R Amygdala and piriform cortex 4.9 10.4 18 -10 -4
4.5 10.1 -22 2 -8
Anterior hypothalamus and R medial amygdala 3.4 3.6 4 0 -18
Deactivation AIR - Androstenol AIR - OO
L Temporal neocortex 4.3 6.0 -58 -54 -2
L, R Parieto-occipital cortex 4.7 1.4 -10 -88 18 4.4 4.0 -10 -84 -6
42 -68 18








General note: Values calculated using SPM2, height threshold at P=0.01, corrected P,0.05.
Talairach’s co-ordinates indicate peak activation; the indicated regions describe coverage of the respective cluster. L = left; R = right.
doi:10.1371/journal.pone.0008651.t001
Androstenol Related Activation
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(AIR – Androstenol and AIR–OO). Congruent with several of
our previous publications with odor stimuli the T-threshold was
calculated at P=0.01, corrected P,0.05 (one group random
effect analysis).
Results
As shown previously, smelling of OO caused activation of the
amygdala, piriform, anterior insular cortex, and portions of the
anterior cingulate cortex. In contrast, smelling of Androstenol
yielded activations in the anterior hypothalamus and the medial
portion of the right amygdala (Table 1, Figure 1, 2). When
lowering the corrected P-value to 0.1, additional cluster
appeared in the left amygdala and piriform cortex, which is
congruent with the notion that the participating subjects
perceived Androstenol as odorous. Deactivations were detected
in the parietal and temporal neocortex with both OO and
Androstenol, and were more pronounced with OO. When
comparing activations caused by OO and Androstenol, a
significant cluster was detected in the right piriform cortex,
(Talairach’s co-ordinates 22 14 -18, cluster size 1.3 cc, Z=4.6
for OO - Androstenol, and -4 1 -5, cluster size 0.9 cc, Z=3.9 for
Androstenol – OO, Figure 1).
Figure 1. Activations and deactivations with androstenol and OO. Upper: Activation and deactivation with Androstenol and OO. Activation
(left) and deactivation (right) detected during smelling of Androstenol, and odors (OO). The OO cluster is located in the amygdala and piriform cortex.
Lower: Difference between activations with Androstenol and odors (OO). The Frontal lobe clusters in the Androstenol – OO contrast were not
significant. Clusters calculated at P=0.01, corrected P,0.05 are superimposed on the standard brain MRI. The Sokoloff’s color scale illustrates T values
reflecting the degree of activation.
doi:10.1371/journal.pone.0008651.g001
Androstenol Related Activation
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(scoring around 50 mm on the Visual Analogue Scale) with respect
to odor familiarity, irritability and pleasantness, (Table 2). The
VAS scores for odor intensity were, however, significantly higher
for OO (7.361.3 vs. 4.462.1; paired T-test, P=0.009). No
significant difference was found in the change in respiratory
amplitude (F=2.2, p=0.13) or frequency (F=0.10, P=0.90)
detected during presentation of Androstenol, OO, or AIR
(Table 3).
Discussion
Androstenol is a bodily released volatile compound, which
has been detected in male sweat. Although this compound is
reported to evoke psychophysical response in humans [15,16],
its role as a potential human pheromone has been questioned
in the absence of studies showing that our brains can detect
signals elicited by smelling of this compound. The observed
pattern of activation with Androstenol was very similar to the
previously detected pattern in heterosexual women and
homosexual men during smelling of AND [9,10,11]. This
similarity is unlikely to be an effect of the steroid structure,
considering that smelling of AND (and also EST) was found to
elicit a dual pattern of activation recruiting primarily the
hypothalamus or the olfactory regions (the amygdala, piriform
and insular cortex), depending of the sex and sexual
orientation of the smeller [9]. The present study shows that
smelling of Androstenol and OO recruits different neuronal
circuits (Figure 1 and 2). Androstenol was deemed to be a
weaker odor than OO, (Table 2), suggesting that the OO-
specific activation in the amygdala and piriform cortex may be
a reflection of intensity. This may, however, not explain lack of
hypothalamus activation by OO. Congruent with our previous
discussions [9,10] we, therefore, suggest that Androstenol, like
AND and EST, may act bimodally, both as an odor and a
pheromone-like compound, and that the hypothalamus acti-
vation is caused by a non-odor component (presumably a
pheromone-like component), whereas the weaker activation of
the medial amygdala and piriform cortex was due to the odor
component.
Androstenol is secreted in sweat. When using human sweat as
the stimulus, Lundstrom et al. detected significant clusters in
the posterior cingulate cortex, the posterior occipital gyrus, the
dorsal postcentral and angular gyrus, but not in the hypothal-
amus (15). The aim of that study was, however, to differentiate
between activations by axillary secrete from kin and non-kin
persons of the same sex, and the results were interpreted to
reflect engagement of self-referential regions. The generated
data were, thus, not directly comparable with the present (15).
Furthermore, sweat contains various compounds with different
properties and mutual interactions, which may lead to more
complicated activation patterns. Nevertheless, it is of interest
that both studies showed a major activation of non-olfactory
regions, suggesting that components of human sweat may affect
the human brain in an odor-unrelated manner. This allows us
to conclude that passive smelling of several different 16-
androstenes activates the brain of healthy heterosexual women,
and that this activation differs from activations by ordinary
odors. The finding that smelling of a previously untested
compound shows a primary engagement of cerebral structures
involved in human reproduction, although entirely new study
group was investigated, motivates further investigations of
human pheromone biology.
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Figure 2. Individual Z-values in the activated clusters.
Graphical presentation of individual Z-values from Talairach’s co-
ordinate 4 0 -18 (peak activation in the hypothalamus cluster derived
from Androstenol – Air, and the Talairach’s coordinates 18 -10 -4 and
-22 2 -8 (peak activations in the right and left amygdala+piriform
cortex clusters derived from OO - Air. The individual values were
obtained from the respective peak co-ordinate by lowering the
uncorrected threshold to P=0.1, which allowed retrieval of the
respective Z-values although they were far below the significance
level for the respective contrast (P=0.01, corrected p,0.05, please
see the main text). The figure illustrates that that the hypothalamus
networks were recruited during smelling of Androstenol, but not OO.
Vertical line indicates Z-values, horizontal line the individual
subjects).
doi:10.1371/journal.pone.0008651.g002
Table 2. Odor ratings.
Pleasantness Intensity Irritability Familiarity
Androstenol 42625 44621 29628 49621
OO 44617 72613** 42625 54612
**p=0.009; the other comparisons in odor ratings were not significant (paired t-
test, P,0.05). OO ratings represent means of ratings for butanol, cedar oil,
lavendel oil and eugenol. The values (mm), expressed as mean and standard
deviation, were generated using Visual Analogue Scale.
doi:10.1371/journal.pone.0008651.t002
Table 3. Respiratory change in amplitude and frequency.
Air (%) Androstenol (%) OO (%)
Amplitude 6.6630.1 30.7643.2 22.9645.8 F=2.2, P=0.13
Frequency 8.761027 10.0614.5 7.8616.0 F=0.10, P=0.90
Values are expressed as mean and standard deviation in the % change of
respiratory frequency and amplitude during scan- vs. prescan-recordings.
doi:10.1371/journal.pone.0008651.t003
Androstenol Related Activation
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